COVID-19

COVID-19 Articles

Lack of social distancing and mask-wearing in some parts of the country, coupled with cold weather that will drive people indoors, may cause a spike in deaths in late fall and early winter. A widely...
Small business owners are gearing up for the 2020 holiday shopping season as business improves slightly. But shop owners are going to have to go the extra mile to attract more customers this year.
The top-performing movie in America for 2020, based on domestic ticket sales, was released right after the start of the year. That gave it two months to accumulate revenue before the COVID-19...
As an approved COVID-19 vaccine nears completion in terms of clinical trials, what can we expect? In the past couple of weeks, firms working toward this goal have taken steps forward and back, which...
Rigel Pharmaceuticals Inc. (NASDAQ: RIGL) has announced that it will push forward with a midstage trial in the treatment of COVID-19.
Sorrento Therapeutics shares jumped on Thursday after the company announced that it received approval from the FDA for its COVID-19 treatment.
WeWork may be successful as companies large and small look for places to park workers. Or, like the movie theater business, it could collapse under the weight of the fear people have of enclosed...
When 30 million confirmed COVID-19 cases globally are reached later this week, there will be a suspicion that the number is not even close to reality.
This year that has seen some of the most dramatic and impactful changes to society, not just in America, but around the world. Jefferies has six surprises and six predictions from its exhaustive...
One of the most widely respected COVID-19 case models forecasts 2.8 million deaths by the end of the year. That means a sharp acceleration in deaths over the next three and a half months.
Practically any biotech company attempting almost anything COVID-19 related has seen massive gains. However, there is likely more to come for the rest of the year and into next year. These five...
iBio has announced that it has selected a vaccine to advance for the prevention of infection by the coronavirus that causes COVID-19.
Co-Diagnostics announced Tuesday that it has entered into an agreement with Arches Research to expand Arches' COVID-19 testing services using Co-Diagnostics’ test kit.
Kamada has announced initial interim results from its ongoing midstage coronavirus study of its treatment of COVID-19 patients with pneumonia.
The Institute for Health Metrics and Evaluation (IHME), one of the most highly regarded forecasters of COVID-19 deaths has issued data that show the number in the U.S. could reach over 600,000 by...